These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8732602)

  • 21. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up.
    Pollock-Barziv SM; Dipchand AI; McCrindle BW; Nalli N; West LJ
    J Heart Lung Transplant; 2005 Feb; 24(2):190-4. PubMed ID: 15701436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
    Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L
    J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
    Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
    Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten- and 20-year survivors of pediatric orthotopic heart transplantation.
    Ross M; Kouretas P; Gamberg P; Miller J; Burge M; Reitz B; Robbins R; Chin C; Bernstein D
    J Heart Lung Transplant; 2006 Mar; 25(3):261-70. PubMed ID: 16507417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Platz KP; Mueller AR; Blumhardt G; Bachmann S; Bechstein WO; Kahl A; Neuhaus P
    Transplantation; 1994 Jul; 58(2):170-8. PubMed ID: 7518975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
    Doria C; Jain AK; Scott VL; Gruttadauria S; Marino IR; Doyle HR; Fung JJ
    Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of cyclosporine A to tacrolimus following heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC
    Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
    Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Jun; 9(3 Pt 1):176-84. PubMed ID: 7549057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
    Swenson JM; Fricker FJ; Armitage JM
    J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P
    J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoplastic disorders after pediatric heart transplantation.
    Bernstein D; Baum D; Berry G; Dahl G; Weiss L; Starnes VA; Gamberg P; Stinson EB
    Circulation; 1993 Nov; 88(5 Pt 2):II230-7. PubMed ID: 8222159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ; Textor SC; Canzanello VJ; Wilson DJ; Wiesner RH; Krom RA
    Am J Hypertens; 1995 Jun; 8(6):598-605. PubMed ID: 7544983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.